pharma · Atopic Dermatitis Eczema · Plaque Psoriasis · ARQT
Arcutis Biotherapeutics
Arcutis Biotherapeutics, Inc is a pharma organization headquartered in Westlake Village, USA. It trades on NYSE under ticker ARQT. Primary therapeutic focus areas include Atopic Dermatitis Eczema, Plaque Psoriasis, Chron
2945 Townsgate Rd, Westlake Village, California 91361, US HQ
2016 Founded
427 Employees
Public company Type
ARQT · NYSE Ticker
Company details
- Status
- Public
- HQ
- 2945 Townsgate Rd, Westlake Village, California 91361, US
- Founded
- 2016
- Employees
- 427
- Programs
- 27
- Drugs
- 3
- Patents
- 30
ARQ-234
Phase 1 · mab · Atopic Dermatitis (AD)
ARQ-234 for Atopic Dermatitis (AD) is a Phase 1 program (mab) at Arcutis Biotherapeutics with 1 ClinicalTrials.gov record(s).
Internal code ARQ-234-131
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Arcutis Biotherapeutics
- Phase
- Phase 1
- Modality
- mab
- Indication
- Atopic Dermatitis (AD)
- Status
- active
- Trials
- 1